Bioinformatics Platform Market Report 2026

Bioinformatics Platform Market Overview

• Bioinformatics Platform market size has reached to $10.44 billion in 2025 • Expected to grow to $15.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To Increasing Demand For Genomic Data Analysis • Market Trend: Advancements In Multiomic Data Mapping Platforms For Enhanced Disease Insights • North America was the largest region in 2025.

What Is Covered Under Bioinformatics Platform Market?

A bioinformatics platform is a comprehensive software framework or system that integrates various tools, algorithms, and databases to facilitate the analysis, interpretation, and management of biological data. It often supports collaborative research, integrating multi-disciplinary knowledge and resources to advance discoveries in healthcare, drug development, and personalized medicine. The main bioinformatics platforms include sequence analysis platforms, sequence alignment platforms, sequence manipulation platforms, structural and functional analysis platforms, and others. A sequence analysis platform refers to a software or toolset designed to process, analyze, and interpret biological sequences, such as DNA, RNA, or protein data. It is applied for genomics, proteomics, drug discovery, personalized medicine, and others by various end-users such as pharmaceutical and biotechnology companies, academic and research institutes, healthcare providers, and others.

What Is The Bioinformatics Platform Market Growth Forecast?

The bioinformatics platform market size is expected to see strong growth in the next few years. It will grow to $15.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine adoption, AI integration in bioinformatics, pharmaceutical R&D expansion, cloud computing adoption in research, demand for faster drug discovery. Major trends in the forecast period include cloud based bioinformatics platforms, AI driven genomic analysis, integrated multi omics data platforms, collaborative research data ecosystems, automated bioinformatics workflows.

Global Bioinformatics Platform Market Segmentation

1) By Platform Type: Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural And Functional Analysis Platforms, Other Platforms 2) By Application: Genomics, Proteomics, Drug Discovery, Personalized Medicine, Other Applications 3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Other End Users Subsegments: 1) By Sequence Analysis Platforms: Whole Genome Sequencing (WGS) Platforms, Targeted Sequencing Platforms, RNA Sequencing Platforms, Metagenomic Sequencing Platforms, Exome Sequencing Platforms 2) By Sequence Alignment Platforms: Global Alignment Tools, Local Alignment Tools, Pairwise Alignment Tools, Multiple Sequence Alignment Tools, Structural Alignment Tools 3) By Sequence Manipulation Platforms: Sequence Assembly Tools, Sequence Editing Tools, Sequence Visualization Tools, Sequence Conversion Tools 4) By Structural And Functional Analysis Platforms: Protein Structure Prediction Tools, Structural Bioinformatics Tools, Functional Annotation Tools, Molecular Docking Platforms, Pathway Analysis Tools 5) By Other Platforms: Data Integration Platforms, Data Visualization Platforms, Bioinformatics Workflow Management Platforms, Cloud-Based Bioinformatics Platforms

What Is The Driver Of The Bioinformatics Platform Market?

The increasing adoption of personalized medicine is anticipated to propel the growth of the bioinformatics platform market in the coming years. Personalized medicine is an approach to healthcare that customizes treatment and prevention strategies based on an individual’s specific genetic profile, lifestyle choices, and environmental influences. The demand for personalized medicine is rising due to advances in genomic technologies, which enable precise identification of genetic variations linked to diseases, allowing for more targeted and effective treatments. The growing demand for personalized medicine drives the need for advanced bioinformatics platforms, as they are essential for analyzing and interpreting vast amounts of genomic and clinical data to develop individualized treatment plans. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based non-profit organization, the FDA authorized 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals granted in 2022. Therefore, the increasing adoption of personalized medicines will boost the growth of the bioinformatics platform industry.

Key Players In The Global Bioinformatics Platform Market

Major companies operating in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Partek Incorporated, Qiagen N.V.,Genedata AG,DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., Golden Helix Inc., Benchling Inc., Velsera Inc., Seqera Labs, Lifebit Biotech Ltd., Genestack Ltd., Biomatters Ltd., Schrödinger Inc., Chemical Computing Group Inc.

Global Bioinformatics Platform Market Trends and Insights

Major companies operating in the bioinformatics platform market are developing technologically advanced solutions, such as multiomic data mapping platforms, to provide accurate insights and a better understanding of complex diseases and conditions. Multiomic data mapping platforms are integrated systems that analyze and correlate data from multiple biological layers, such as genomics, transcriptomics, proteomics, and metabolomics, to provide a comprehensive understanding of complex biological processes. For instance, in February 2023, BioSkryb Genomics, a US-based biotechnology company, launched the BaseJumper Bioinformatics Platform. This platform is designed to enhance the ResolveOME system by simplifying large-scale single-cell informatics. It enables quick organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, streamlining data interpretation. The platform offers dynamic filtering and a suite of visualization tools, allowing researchers across disciplines to easily analyze and visualize complex datasets.

What Are Latest Mergers And Acquisitions In The Bioinformatics Platform Market?

In April 2023, Excelra, an India-based informatics company, acquired BISC Global for an undisclosed amount. The acquisition forms a global leader in consulting-driven bioinformatics, combining expertise in artificial intelligence, machine learning, and omics and next-generation sequencing data analysis. This merger will drive bioinformatics innovation and provide enhanced benefits to customers from both organizations. BISC Global is a Germany-based provider of bioinformatics platforms.

Regional Insights

North America was the largest region in the bioinformatics platform market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Bioinformatics Platform Market?

The bioinformatics platform market consists of revenues earned by entities by providing services such as transcriptomics services, data integration and visualization, custom pipeline development, and training and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics platform market also includes sales of biological databases, cloud computing platforms, genome annotation tools, and clinical interpretation tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioinformatics Platform Market Report 2026?

The bioinformatics platform market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics platform industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.